Product Name | MF | CAS | Details |
---|
Trazodone impurity 2/Trazodone 4-Chloro Analog/2-{3-[4-(4-Chlorophenyl)piperazin-1-yl]propyl}-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one | C19H22ClN5O | 157072-19-0 | Details |
Omeprazole impurity 12/Omeprazole N-Methyl 6-Methoxy Analog/6-methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1-methyl-1H-benzo[d]imidazole | C18H21N3O3S | 784143-42-6 | Details |
Indomethacin impurity 2/Indomethacin EP Impurity C/4-Chloro-N-(4-methoxyphenyl)-benzamide | C14H12ClNO2 | 4018-82-0 | Details |
Nateglinide impurity 1/Nateglinide Methyl Ester/methyl (2S)-3-phenyl-2-{[(1r,4r)-4-(propan-2-yl)cyclohexyl]formamido}propanoate | C20H29NO3 | 105746-47-2 | Details |
Esomeprazole impurity 5/4sodium 2-(((3,5-dimethyl-4-oxidopyridin-2-yl)methyl)sulfinyl)-5-methoxybenzo[d]imidazol-1-ide | C16H18N3NaO3S | 1803449-15-1 | Details |
Racecadotril impurity 1/Racecadotril EP impurity B/Thiorphan/[[(2RS)-2-benzyl-3-sulfanylpropanoyl]amino]acetic acid | C12H15NO3S | 76721-89-6 | Details |
Gefitinib impurity 6/O-Desmethyl Gefitinib/4-((3-chloro-4-fluorophenyl)amino)-6-(3-morpholinopropoxy)quinazolin-7-ol | C21H22ClFN4O3 | 847949-49-9 | Details |
Umeclidinium bromide impurity 1/1-Azabicyclo[2.2.2]octane-4-carboxylic acid | C8H13NO2 | 55022-88-3 | Details |
Gefitinib impurity 15/4-Defluoro-4-Hydroxy Gefitinib/2-chloro-4-((7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-yl)amino)phenol | C22H25ClN4O4 | 847949-50-2 | Details |
NateglinideEPImpurityF | C28H36N2O4 | 944746-48-9 | Details |
Clozapine impurity 4/Clozapine EP Impurity D/Clozapine impurity B (USP)/(2-((2-amino-4-chlorophenyl)amino)phenyl)(4-methylpiperazin-1-yl)methanone | C18H21ClN4O | 65514-71-8 | Details |
Regorafenib impurity 3/Regorafenib Urea Impurity/1-(4-chloro-3-(trifluoromethyl)phenyl)-3-(2-fluoro-4-hydroxyphenyl)urea | C14H9ClF4N2O2 | 1333390-56-9 | Details |
Itopride impurity 4/3,4-Dimethoxy-N-[4-(2-methylamino-ethoxy)-benzyl]benzamide | C19H24N2O4 | 141996-97-6 | Details |
Solifenacin impurity 3/Solifenacin EP Impurity C/Solifenacin (S,S) Methanone Impurity/Bis[(1S)-3,4-dihydro-1-phenyl-2(1H)-isoquinolinyl]-methanone | C31H28N2O | 1534326-81-2 | Details |
Apixaban impurity 17/Methyl 6-(4-aminophenyl)-1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate | C21H20N4O4 | 1466571-07-2 | Details |
Apixaban impurity 5/1-(4-chlorophenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo\[3,4-c]pyridine-3-carboxamide | C24H22ClN5O3 | 2029205-64-7 | Details |
Umeclidinium bromide impurity 3/1-[2-(Benzoyloxy)ethyl]-4-(hydroxydiphenylmethyl)-1-azoniabicyclo[2.2.2]octane bromide | C29H32BrNO3 | 869113-45-1 | Details |
Omeprazole impurity 2/Omeprazole Pyridone Acid Ammonium Salt/1,4-Dihydro-1-(5-methoxy-1H-benzimidazol-2-yl)-3,5-dimethyl-4-oxo-2-pyridinecarboxylic Acid Ammonium Salt | C16H18N4O4 | 2227107-89-1 | Details |
Lansoprazole impurity 2/Lansoprazole EP Impurity B/Lansoprazole Sulfone/2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl]sulfonyl]-1H-benzimidazole | C16H14F3N3O3S | 131926-99-3 | Details |
Gefitinib impurity 7/3-Desmorpholinyl-3-hydroxyethylamino Gefitinib/2-((3-((4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)propyl)amino)ethan-1-ol | C20H22ClFN4O3 | 847949-56-8 | Details |
Irbesartan impurity 2/Demethyl Irbesartan/Irbesartan Propyl Analog/2-Propyl-3-[[2-(2H-tetrazol-5-yl)[1,1-biphenyl]-4-yl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one | C24H26N6O | 158778-58-6 | Details |
Umeclidinium bromide impurity 4/4-(Hydroxydiphenylmethyl)-1-(2-hydroxyethyl)-1-azoniabicyclo[2.2.2]octane bromide | C22H28BrNO2 | 869112-31-2 | Details |
Itopride impurity 5/Itopride N-Oxide/2-(4-((3,4-dimethoxybenzamido)methyl)phenoxy)-N,N-dimethylethan-1-amine oxide | C20H26N2O5 | 141996-98-7 | Details |
Esomeprazole impurity 8/2-Chloromethyl-4-methoxy-3,5-dimethylpyridine 1-Oxide | C9H12ClNO2 | 848694-10-0 | Details |
Solifenacin impurity 10/Solifenacin R Isomer/(R)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline | C15H15N | 180272-45-1 | Details |
Apixaban impurity 1/1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate | C26H26N4O5 | 1074365-84-6 | Details |
Indomethacin impurity 5/Indomethacin EP Impurity F/2-(4-Chlorobenzoyl)-1-(4-methoxyphenyl)hydrazide-4-chloro-benzoic acid | C21H16Cl2N2O3 | 402849-27-8 | Details |
Topiroxostat impurity 4/4-Amino-3,5-bis(4-pyridyl)-1,2,4-triazole | C12H10N6 | 38634-05-8 | Details |
Loxoprofen impurity 1/2-(4-(hydroxymethyl)phenyl)propanoic acid | C10H12O3 | 88416-60-8 | Details |
Lansoprazole impurity 3/Lansoprazole EP Impurity C/Lansoprazole Sulfide/2-(((3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methyl)thio)-1H-benzo[d]imidazole | C16H14F3N3OS | 103577-40-8 | Details |
Lacosamide impurity 8/Lacosamide EP Impurity H/(S)-2-acetamido-N-((S)-1-(benzylamino)-3-methoxy-1-oxopropan-2-yl)-3-methoxypropanamide | C17H25N3O5 | 1375090-19-9 | Details |
Lansoprazole impurity 7/Lansoprazole Sulfone N-Oxide/2-(((1H-benzo[d]imidazol-2-yl)sulfonyl)methyl)-3-methyl-4-(2,2,2- trifluoroethoxy)pyridine 1-oxide | C16H14F3N3O4S | 953787-54-7 | Details |
Trazodone impurity 6/Trazodone N-Oxide/2-[3-[4-(3-Chlorophenyl)-1-oxido-1-piperazinyl]propyl]-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one | C19H22ClN5O2 | 55290-68-1 | Details |
Irbesartan impurity 1/Irbesartan Cyano Impurity/4'-[(2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]biphenyl-2-carbonitrile | C25H27N3O | 138401-24-8 | Details |
Solifenacin impurity 9/(1S)-3,4-Dihydro-1-phenyl-2(1H)-isoquinolinecarbonyl Chloride | C16H14ClNO | 1195949-26-8 | Details |
Loxoprofen impurity 6/2-[(4-Acetylphenyl)methyl]cyclopentan-1-one | C14H16O2 | 96824-28-1 | Details |
Solifenacin impurity 2/Solifenacin EP Impurity B/(1S)-3,4-Dihydro-1-phenyl-2(1H)-isoquinolinecarboxylic Acid 1-Methylethyl Ester | C19H21NO2 | 1353274-25-5 | Details |
Itopride impurity 1/4-[2-(Dimethylamino)ethoxy]benzylamine | C11H18N2O | 20059-73-8 | Details |
Clozapine impurity 5/Clozapine N-Oxide/4-(8-chloro-5H-dibenzo[b,e][1,4]diazepin-11-yl)-1-methylpiperazine 1-oxide | C18H19ClN4O | 34233-69-7 | Details |
Omeprazole impurity 16/Omeprazole Hydroxymethyl HCl/(4-Methoxy-3,5-dimethylpyridin-2-yl)methanol Hydrochloride | C9H13NO2HCl | 96300-88-8 | Details |
Ketoprofen impurity 1/Ketoprofen EP Impurity A/1-(3-benzoylphenyl)ethan-1-one | C15H12O2 | 66067-44-5 | Details |
Omeprazole impurity 14/4-Desmethoxy Omeprazole Sulfide/2-(((3,5-dimethylpyridin-2-yl)methyl)thio)-6-methoxy-1H-benzo[d]imidazole | C16H17N3OS | 704910-89-4 | Details |
Irbesartan impurity 3/N-((2’-cyanobiphenyl-4-yl)methyl)-1-pentanamido cyclopentane carboxamide | C25H29N3O2 | 141745-71-3 | Details |
Lacosamide impurity 5/Lacosamide EP Impurity E/Desacetyl Desmethyl Lacosamide/(2R)-2-Amino-3-hydroxy-N-(phenylmethyl)-propanamide | C10H14N2O2 | 175481-39-7 | Details |
Cimetidine impurity 8/Cimetidine EP Impurity H/1,1′-(Disulfanediyldiethylene)bis(2-cyano-3-methylguanidine) | C10H18N8S2 | 74886-59-2 | Details |
Lacosamide impurity 10/Lacosamide EP Impurity K/2-acetamido-N-benzylacrylamide | C12H14N2O2 | 86921-49-5 | Details |
Cimetidine impurity 6/Cimetidine EP Impurity F/Cimetidine bis Impurity/2-Cyano-1,3-bis[2-[[(5-methyl-1H-imidazol-4-yl)methyl]-sulfanyl]ethyl] guanidine | C16H24N8S2 | 55272-86-1 | Details |
Indomethacin impurity 1/5-methoxy-2-methyl-1H-Indole-3-acetic acid | C12H13NO3 | 2882-15-7 | Details |
10-Formyl Folic Acid | C20H19N7O7 | 134-05-4 | Details |
Solifenacin impurity 1/Solifenacin EP Impurity A/Solifenacin S Isomer/(S)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline | C15H15N | 118864-75-8 | Details |
Cimetidine impurity 2/Cimetidine EP Impurity B/Cimetidine Methoxy Analog/Methyl 3-cyano-1-[2-[[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl]ethyl]-carbamimidate | C10H15N5OS | 138035-55-9 | Details |
2-(1,6-dimethylpiperidin-3-yl)propan-2-ol | C10H21NO | 91342-95-9 | Details |
Loxoprofen impurity 11/2-(4-((1-(Methoxycarbonyl)-2-oxocyclopentyl)methyl)phenyl)propanoic Acid | C17H20O5 | 1027957-36-3 | Details |
Lansoprazole impurity 11/2,3-dimethyl-4-(2,2,2-trifluoroethoxy)pyridine 1-oxide | C9H10F3NO2 | 103577-61-3 | Details |
Omeprazole impurity 19/4-Desmethoxy-4-chloro Omeprazole Sulfide/2-[[(4-Chloro-3,5-dimethyl-2-pyridinyl)methyl]thio]-6-methoxy-1H-benzimidazole | C16H16ClN3OS | 220757-74-4 | Details |
Solifenacin impurity 8/Solifenacin Ethyl Ester Impurity/(1S)-3,4-Dihydro-1-phenyl-2(1H)-isoquinolinecarboxylic acid ethyl ester | C18H19NO2 | 180468-42-2 | Details |
Trazodone impurity 1/Deschloro Trazodone/2-[3-(4-Phenyl-1-piperazinyl)propyl]-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one | C19H23N5O | 62337-66-0 | Details |
Indomethacin impurity 8/Indomethacin EP impurity I/ethyl 2-(1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)acetate | C21H20ClNO4 | 16401-99-3 | Details |
Fasudil impurity 8/Fasudil N-Hydroxy HCl Impurity/5-[(Hexahydro-4-hydroxy-1H-1,4-diazepin-1-yl)sulfonyl]isoquinoline hydrochloride | C14H17N3O3S | 1350827-92-7 | Details |
Indomethacin impurity 4/Indomethacin EP impurity E/2-(1-(3-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)acetic acid | C19H16ClNO4 | 807614-94-4 | Details |
Trazodone impurity 4/4-Ethyl Trazodone/2-[3-[4-(3-Chloro-4-ethylphenyl)-1-piperazinyl]propyl]-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one | C21H26ClN5O | 1346599-35-6 | Details |
Fasudil impurity 12/5-(1,4-diazepan-1-ylsulfonyl)-2H-isoquinolin-1-one hydrochloride | C14H17N3O3S | 105628-72-6 | Details |
Clozapine impurity 3/Clozapine EP Impurity C/Clozapine impurity A (USP)/8-chloro-11-(piperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine | C17H17ClN4 | 6104-71-8 | Details |
Lacosamide impurity 1/Lacosamide EP Impurity A/(S)-2-(Acetylamino)-3-methoxy-N-(phenylmethyl)propanamide | C13H18N2O3 | 175481-37-5 | Details |
Omeprazole impurity 10/4-Hydroxy Omeprazole Sulfide/Omeprazole Pyridone/2-[[(6-Methoxy-1H-benzimidazol-2-yl)thio]methyl]-3,5-dimethyl-4-pyridinol | C16H17N3O2S | 103876-98-8 | Details |
Esomeprazole impurity 3/4-Methoxy-2-(((5-methoxy-1H-benzo[d]imidazol-2-yl)thio)methyl)-3,5-dimethylpyridine 1-oxide | C17H19N3O3S | 142885-92-5 | Details |
Lacosamide impurity 2/Lacosamide EP Impurity B/Lacosamide O-Acetyl Impurity/(2R)-2-(Acetylamino)-3-(acetyloxy)-N-(phenylmethyl)-propanamide | C14H18N2O4 | 1318777-54-6 | Details |
Apixaban impurity 15/6-(4-aminophenyl)-1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide | C20H19N5O3 | 1423803-24-0 | Details |
Esomeprazole impurity 9/ Des-ethylsulfinyl-methoxybenzoimidazole 2-Acetyloxy Esomeprazole | C11H15NO3 | 91219-90-8 | Details |
Loxoprofen impurity 7/2-(4-(2-oxo cyclopentylmethyl)phenyl)propionic acidmethyl ester | C16H20O3 | 81762-92-7 | Details |
Indomethacin impurity 7/Indomethacin EP Impurity H/methyl 2-(1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)acetate | C20H18ClNO4 | 1601-18-9 | Details |
(15R)-Bimatoprost Acid/(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3R)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-5-heptenoic Acid | C23H32O5 | 41639-71-8 | Details |
Lacosamide impurity 6/Lacosamide EP Impurity F/(2R)-2-(Acetylamino)-3-hydroxy-N-(phenylmethyl)propanamide | C12H16N2O3 | 175481-38-6 | Details |
Repaglinide impurity 1/Repaglinide EP Impurity A/4-Carboxy-3-ethoxybenzeneacetic acid | C11H12O5 | 220438-80-2 | Details |
Racecadotril impurity 5/Racecadotril EP Imurity G/benzyl [[(2RS)-2-benzyl-3-sulfanylpropanoyl]amino]acetate | C19H21NO3S | 81110-69-2 | Details |
Indomethacin impurity 6/Indomethacin impurity G/2-(1-(3,4-dichlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)acetic acid | C19H15Cl2NO4 | 402849-26-7 | Details |
Trazodone impurity 3/Trazodone Bromo Analog/2-{3-[4-(3-Bromophenyl)piperazin-1-yl]propyl}-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one | C19H22BrN5O | 1263358-13-9 | Details |
Product Total: Product Page: | ||||
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 |